Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
1(5%)
Results Posted
54%(7 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
1
5%
Ph phase_4
8
42%
Ph phase_3
4
21%
Ph phase_1
6
32%

Phase Distribution

6

Early Stage

1

Mid Stage

12

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
6(31.6%)
Phase 2Efficacy & side effects
1(5.3%)
Phase 3Large-scale testing
4(21.1%)
Phase 4Post-market surveillance
8(42.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

19

all time

Status Distribution
Active(1)
Completed(13)
Terminated(2)
Other(3)

Detailed Status

Completed13
unknown3
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
1
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (31.6%)
Phase 21 (5.3%)
Phase 34 (21.1%)
Phase 48 (42.1%)

Trials by Status

completed1368%
recruiting15%
withdrawn15%
terminated15%
unknown316%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT03771313Phase 4

Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic Fibrosis

Completed
NCT02735707Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
NCT01734694Phase 4

Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients

Terminated
NCT03025841Phase 1

Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance

Completed
NCT02600793Phase 1

Ceftaroline Diffusion Into Cerebrospinal Fluid of Children

Unknown
NCT02660346Phase 4

IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB

Completed
NCT01371838Phase 3

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Completed
NCT01458743Phase 1

Ceftaroline China Pharmacokinetics Study

Completed
NCT01290900Phase 1

A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers

Completed
NCT00633152Phase 2

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Completed
NCT00423657Phase 3

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Completed
NCT00633126Phase 1

Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Completed
NCT00424190Phase 3

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Completed
NCT02582203Phase 4

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

Completed
NCT02937181Phase 4

Antibiotic Prophylaxis in Open Fractures

Unknown
NCT01524302Phase 4

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia

Completed
NCT02307006Phase 4

The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection

Unknown
NCT02005068Phase 4

Ceftaroline in the Treatment of Bone and Joint Infections

Withdrawn
NCT01648127Phase 1

Pharmacokinetics of Ceftaroline in Normal and Obese Subjects

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19